ArticleLung2024

Circulating Osteopontin Predicts Clinical and Radiological Response in First-Line Treatment of Advanced Non-Small Cell Lung Cancer.

Davide Ramoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.